Does the trade of medical products contribute to promoting human development?—An empirical analysis based on data from China and RCEP countries
Bibliographic Data
| ID | 22073288 |
|---|---|
| Authors | Liang Wu (0000-0002-5208-7318), Wu Liang (0000-0001-6729-0768, Huzhou University), Wenxia Liu (0000-0001-5993-1000, Huzhou University), Jianhua Zhou (0000-0002-2104-8279, Huzhou University), Dan Zhou (0000-0001-8678-8270, Huzhou University), Hanjie Xiao (0000-0002-4300-3354, Huzhou University, corresponding author) |
| Year | 2025 |
| Volume | 13 |
| Pages | 1650225-1650225 |
| Publication date | 2025-08-13 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Public Health (JOURNAL) |
| Journal identifiers | ISSN: 2296-2565 • E-ISSN: 2296-2565 |
| Publisher | Frontiers Media SA (PUBLISHER • CH) |
| DOI | 10.3389/fpubh.2025.1650225 |
| PMID | 40880920 |
| OpenAlex | W4413178117 |
| Language | EN |
| References cited | 43 |
Background: As the RCEP (Regional Comprehensive Economic Partnership) Agreement deepens, the role of medical product trade in safeguarding regional public health security and promoting economic development has become increasingly prominent. Methods: Based on data from 2004 to 2023, this study employs the stochastic frontier gravity model and benchmark regression model to explore the impact of China's medical product export efficiency on the development indices of RCEP countries. Results: The findings are as follows: (1) China's medical product exports to RCEP countries exhibit simultaneous scale expansion, structural differentiation, and market concentration, with ASEAN, Japan, and South Korea as core markets and mid-to-low-end products dominating the export structure; (2) Trade efficiency evolution reflects dual mechanisms of institutional environment and technological capabilities, where governance levels and health system soundness optimize efficiency, while excessive liberalization and tax burdens increase friction costs; (3) Enhanced export efficiency indirectly promotes human development in RCEP countries by strengthening basic health service coverage, forming a "trade-health-development" transmission mechanism. Conclusion: To enhance export efficiency and achieve synergistic development, we propose: (1) For policymakers: Deepen institutional coordination and establish a "trade-health" collaborative governance framework to amplify public health dividends; (2) For exporters: Implement a tiered market strategy and strengthen technological innovation to enhance industrial resilience
Business · China · Industrial organization · International trade · Global Healthcare and Medical Tourism · Healthcare Systems and Reforms · Pharmaceutical Economics and Policy
Global Trade Pattern of Medical Devices and China's Trade Position
Medical Device Product Innovation Choices in Asia
Impact of the Covid-19 epidemic on medical product imports from china from outbreak to stabilization
Traditional Chinese medicine trade among RCEP countries
Measuring the Market Power of China's Medical Product Exports
The influence of digital platform on the implementation of corporate social responsibility
Regulatory convergence within technical barriers to trade
Sicken thy neighbour
Defending access to medicines in regional trade agreements
Distribution incidence, mortality of tuberculosis and human development index in Iran
International accreditation, linguistic proximity and trade in medical services
| Citation velocity | historical |
|---|---|
| Highly cited | No |